The obesity-induced transcriptional regulator TRIP-Br2 mediates visceral fat endoplasmic reticulum stress-induced inflammation

Nature Communications

Volumn 7, Issue , 2016, Pages

  Qiang, Guifen ^a   Kong, Hyerim Whang ^a   Fang, Difeng ^b   McCann, Maximilian ^a   Yang, Xiuying ^c   Du, Guanhua ^c   Blüher, Matthias ^d   Zhu, Jinfang ^b   Liew, Chong Wee ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c INSTITUTE OF MATERIA MEDICA   (China)

^d UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CYTOKINE; FATTY ACID; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; TATA BINDING PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GATA 1; TRANSCRIPTION FACTOR GATA 2; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR TRIP BR2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ADIPOCYTOKINE; GATA3 PROTEIN, MOUSE; SERTAD2 PROTEIN, MOUSE;

BIOASSAY; CELLS AND CELL COMPONENTS; FAT; GENE EXPRESSION; HEALTH RISK; METABOLISM; OBESITY; PHYSIOLOGY; PROTEIN;

ACUTE PHASE RESPONSE; ADIPOCYTE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; CYTOKINE RESPONSE; ENDOPLASMIC RETICULUM STRESS; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; INTRAABDOMINAL FAT; MACROPHAGE; MALE; MOUSE; NONHUMAN; OBESITY; PROADIPOCYTE; PROMOTER REGION; PROTEIN EXPRESSION; UPREGULATION; WHITE ADIPOSE TISSUE; ANIMAL; C57BL MOUSE; GENETICS; IMMUNOLOGY; INTRA-ABDOMINAL FAT; PATHOPHYSIOLOGY;

ADIPOCYTES; ADIPOKINES; ANIMALS; ENDOPLASMIC RETICULUM STRESS; GATA3 TRANSCRIPTION FACTOR; HUMANS; INTRA-ABDOMINAL FAT; MALE; MICE; MICE, INBRED C57BL; OBESITY; TRANSCRIPTION FACTORS;

EID: 84964584107     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms11378     Document Type: Article

References (43)

1. Kahn, B. B. & Flier, J. S. Obesity and insulin resistance. J. Clin. Invest. 106, 473-481 (2000).
2. Gesta, S., Tseng, Y. H. & Kahn, C. R. Developmental origin of fat: tracking obesity to its source. Cell 131, 242-256 (2007).
3. Klein, S. et al. Waist circumference and cardiometabolic risk: a consensus statement from shaping America's health: Association for Weight Management and Obesity Prevention; NAASO, the Obesity Society; the American Society for Nutrition; and the American Diabetes Association. Diabetes Care 30, 1647-1652 (2007).
4. Snijder, M. B. et al. Associations of hip and thigh circumferences independent of waist circumference with the incidence of type 2 diabetes: the Hoorn Study. Am. J. Clin. Nutr. 77, 1192-1197 (2003).
5. Foster, M. T. et al. Subcutaneous adipose tissue transplantation in diet-induced obese mice attenuates metabolic dysregulation while removal exacerbates it. Physiol. Rep. 1, e00015 (2013).
6. Tran, T. T., Yamamoto, Y., Gesta, S. & Kahn, C. R. Beneficial effects of subcutaneous fat transplantation on metabolism. Cell Metab. 7, 410-420 (2008).
7. Manolopoulos, K. N., Karpe, F. & Frayn, K. N. Gluteofemoral body fat as a determinant of metabolic health. Int. J. Obes. (Lond.) 34, 949-959 (2010).
8. Lee, M. J., Wu, Y. & Fried, S. K. Adipose tissue heterogeneity: implication of depot differences in adipose tissue for obesity complications. Mol. Aspects Med. 34, 1-11 (2013).
9. Tchkonia, T. et al. Mechanisms and metabolic implications of regional differences among fat depots. Cell Metab. 17, 644-656 (2013).
10. Gesta, S. et al. Evidence for a role of developmental genes in the origin of obesity and body fat distribution. Proc. Natl Acad. Sci. USA 103, 6676-6681 (2006).
11. Macotela, Y. et al. Intrinsic differences in adipocyte precursor cells from different white fat depots. Diabetes 61, 1691-1699 (2012).
12. Vohl, M. C. et al. A survey of genes differentially expressed in subcutaneous and visceral adipose tissue in men. Obes. Res. 12, 1217-1222 (2004).
13. Karastergiou, K. et al. Distinct developmental signatures of human abdominal and gluteal subcutaneous adipose tissue depots. J. Clin. Endocrinol. Metab. 98, 362-371 (2013).
14. Lee, K. Y. et al. Shox2 is a molecular determinant of depot-specific adipocyte function. Proc. Natl Acad. Sci. USA 110, 11409-11414 (2013).
15. Liew, C. W. et al. Ablation of TRIP-Br2, a regulator of fat lipolysis, thermogenesis and oxidative metabolism, prevents diet-induced obesity and insulin resistance. Nature Med. 19, 217-226 (2013).
16. Weisberg, S. P. et al. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 112, 1796-1808 (2003).
17. Xu, H. et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 112, 1821-1830 (2003).
18. Fischer-Posovszky, P., Newell, F. S., Wabitsch, M. & Tornqvist, H. E. Human SGBS cells - a unique tool for studies of human fat cell biology. Obes. Facts 1, 184-189 (2008).
19. Ozcan, U. et al. Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science 313, 1137-1140 (2006).
20. Tchkonia, T. et al. Fat depot-specific characteristics are retained in strains derived from single human preadipocytes. Diabetes 55, 2571-2578 (2006).
21. Ozcan, U. et al. Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 306, 457-461 (2004).
22. Heinz, S. et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol. Cell 38, 576-589 (2010).
23. Heinemeyer, T. et al. Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL. Nucleic Acids Res. 26, 362-367 (1998).
24. Sandelin, A., Alkema, W., Engstrom, P., Wasserman, W. W. & Lenhard, B. JASPAR: an open-access database for eukaryotic transcription factor binding profiles. Nucleic Acids Res. 32, D91-D94 (2004).
25. Messeguer, X. et al. PROMO: detection of known transcription regulatory elements using species-tailored searches. Bioinformatics 18, 333-334 (2002).
26. Tong, Q. et al. Function of GATA transcription factors in preadipocyteadipocyte transition. Science 290, 134-138 (2000).
27. Tong, Q., Tsai, J., Tan, G., Dalgin, G. & Hotamisligil, G. S. Interaction between GATA and the C/EBP family of transcription factors is critical in GATA-mediated suppression of adipocyte differentiation. Mol. Cell. Biol. 25, 706-715 (2005).
28. Berndt, J. et al. Plasma visfatin concentrations and fat depot-specific mRNA expression in humans. Diabetes 54, 2911-2916 (2005).
29. Nakano, Y. et al. Oral administration of K-11706 inhibits GATA binding activity, enhances hypoxia-inducible factor 1 binding activity, and restores indicators in an in vivo mouse model of anemia of chronic disease. Blood 104, 4300-4307 (2004).
30. Fang, T. C. et al. Notch directly regulates Gata3 expression during T helper 2 cell differentiation. Immunity 27, 100-110 (2007).
31. Zhu, J. et al. Conditional deletion of Gata3 shows its essential function in T(H)1-T(H)2 responses. Nat. Immunol. 5, 1157-1165 (2004).
32. Hotamisligil, G. S. Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell 140, 900-917 (2010).
33. Goldfine, A. B. et al. Targeting inflammation using salsalate in patients with type 2 diabetes: effects on flow-mediated dilation (TINSAL-FMD). Diabetes Care 36, 4132-4139 (2013).
34. Kawashiri, S. Y. et al. Effects of the anti-interleukin-6 receptor antibody, tocilizumab, on serum lipid levels in patients with rheumatoid arthritis. Rheumatol. Int. 31, 451-456 (2011).
35. Tchkonia, T. et al. Identification of depot-specific human fat cell progenitors through distinct expression profiles and developmental gene patterns. Am. J. Physiol. Endocrinol. Metab. 292, E298-E307 (2007).
36. Mauer, J. et al. Signaling by IL-6 promotes alternative activation of macrophages to limit endotoxemia and obesity-associated resistance to insulin. Nat. Immunol. 15, 423-430 (2014).
37. Wernstedt Asterholm, I. et al. Adipocyte inflammation is essential for healthy adipose tissue expansion and remodeling. Cell Metab. 20, 103-118 (2014).
38. Jimenez, V. et al. In vivo adeno-associated viral vector-mediated genetic engineering of white and brown adipose tissue in adult mice. Diabetes 62, 4012-4022 (2013).
39. Shin, K. J. et al. A single lentiviral vector platform for microRNA-based conditional RNA interference and coordinated transgene expression. Proc. Natl Acad. Sci. USA 103, 13759-13764 (2006).
40. Tseng, Y. H. et al. New role of bone morphogenetic protein 7 in brown adipogenesis and energy expenditure. Nature 454, 1000-1004 (2008).
41. Tseng, Y. H., Kriauciunas, K. M., Kokkotou, E. & Kahn, C. R. Differential roles of insulin receptor substrates in brown adipocyte differentiation. Mol. Cell. Biol. 24, 1918-1929 (2004).
42. Boucher, J. et al. Impaired thermogenesis and adipose tissue development in mice with fat-specific disruption of insulin and IGF-1 signalling. Nat. Commun. 3, 902 (2012).
43. Liew, C. W. et al. The pseudokinase tribbles homolog 3 interacts with ATF4 to negatively regulate insulin exocytosis in human and mouse beta cells. J. Clin. Invest. 120, 2876-2888 (2010).